AI-driven deciphering of genetic diseases
Nostos Genomics has raised $5.7M in total funding. The most recent round was Seed. The last funding was announced in February 2022.
Nostos Genomics's investors include Entrepreneurs First, Acequia Capital (AceCap), Creative Destruction Lab, 42CAP, Charlie Songhurst.
Nostos Genomics is headquartered in Berlin, Germany.
AI-driven deciphering of genetic diseases
Nostos Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nostos Genomics — Funding & Investors." VCBacked, February 3, 2022, https://www.vcbacked.co/company/nostos-genomics. Accessed September 29, 2026.
VCBacked. (2022). Nostos Genomics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/nostos-genomics
{{cite web |title=Nostos Genomics — Funding & Investors |url=https://www.vcbacked.co/company/nostos-genomics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated